Who owns iShares NASDAQ Biotechnology Index?

Key details on iShares NASDAQ Biotechnology Index (Ticker: IBB)

Who owns iShares NASDAQ Biotechnology Index?

Is IBB a good stock to own? Find out who bought iShares NASDAQ Biotechnology Index, who sold iShares NASDAQ Biotechnology Index (IBB) stock, and who holds a large position in iShares NASDAQ Biotechnology Index.

Fund Name Number of Shares Share Valuation As Of
GOLDMAN SACHS 2.96M $1.00B Dec. 31, 2015
SUSQUEHANNA INTERNATIONAL 2.43M $822.98M Dec. 31, 2015
Bank of America Corporation 1.98M $670.69M Dec. 31, 2015
MORGAN STANLEY 1.84M $621.64M Dec. 31, 2015
Citi 1.65M $558.88M Dec. 31, 2015
JANE STREET 1.55M $523.38M Dec. 31, 2015
Deutsche Bank Aktiengesellschaft 1.54M $467.06M Dec. 31, 2014
UBS AG 1.40M $383.28M Sept. 30, 2014
Schroder Investment Management 1.37M $287.49M Sept. 30, 2013
Credit Suisse AG 1.13M $341.74M Sept. 30, 2015
Archer Capital Management 980000 $81.15M March 31, 2012
BNP PARIBAS ARBITRAGE, SNC 859187 $212.49M March 31, 2016
HAP Trading 779600 $14.08M June 30, 2014
UBS Group AG 761464 $257.63M Dec. 31, 2015
JPMORGAN CHASE & CO 715710 $243.34M Dec. 31, 2015
Mirae Asset Global Investments 699344 $165.05M March 31, 2014
Churchill Management 594625 $152.84M June 30, 2014
Allianz Asset Management AG 546441 $114.53M Sept. 30, 2013
Wells Fargo & Company 480332 $162.51M Dec. 31, 2015
Mariner Investment 475700 $124.07M March 31, 2016
Barclays 470935 $159.18M Dec. 31, 2015
Bank of Nova Scotia 456000 $103.54M Dec. 31, 2013
Beaumont Financial Partners 451189 $154.95M March 31, 2015
SERENGETI ASSET MANAGEMENT 450000 $136.51M Dec. 31, 2014

Who sold iShares NASDAQ Biotechnology Index?

Fund Name Date Sold Number of Shares Sold Share Valuation
Johnson Investment Counsel June 30, 2011 8.02M $543.35M
Royal Bank of Scotland June 30, 2011 710459 $75.78M